Coming Special Issue
Expiring Date:
Dec. 10, 2019
Submit a Manuscript
share
Special Issues
Expand the Popularity of Your Conference
Publish conference papers as a Special Issue
Send your Special Issue proposal to:
special.issues@sciencepublishinggroup.com
Submit Hot Topics
Submit
If you wish to order hard copies, please click here to know more information.
Lymphoma
Lead Guest Editor:
Anil Tombak
Guest Editors
Elif Birtas Atesoglu
Anadolu Saglik Merkezi
 Kocaeli, Turkey
Mahmut Yeral
Baskent University
Ankara, Turkey
Ozgur Mehtap
Kocaeli University
Kocaeli, Turkey
Demircan Ozbalci
Suleyman Demirel University
Almaty, Turkey
Gökhan Özgür
Department of Hematology
Ankara, Turkey
Fusun Gediz
Bozyaka Research and Training Hospital
Izmir, Turkey
Introduction
Lymphomas consists of a diverse group of malignant neoplasms. They derived from B cell progenitors, T cell progenitors, mature B cells, mature T cells, or natural killer cells. The World Health Organization (WHO) classifies tumors of the hematopoietic and lymphoid tissues according to their morphologic, immunophenotypic, genetic, and clinical features and this classification was revised in 2016. The pathogenesis of lymphomas still continues to dissolve and new biological subtypes are identified, and new information is added. These developments and changes bring new suggestions for the diagnostic, prognostic evaluation and treatment of lymphomas. A large number of new agents were introduced for the the treatment of lymphomas in the last 20 years. New monoclonal antibodies and targeted agents acting on each of its specific mechanisms have been successfully applied to different lymphoma subtypes. In addition, phase studies of many agents are still ongoing, and the introduction of a significant number of patients into these studies is a necessity in today's lymphoma treatment practice.

Aims and Scope:

  1. Lymphoma
  2. Chemotherapy
  3. Antibodies
  4. Biology
  5. Small molecules
  6. Molecular pathogenesis
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186